Search Results 941-950 of 17853 for corticosteroid

1. A Study to Evaluate the Effectiveness and Tolerability of a Topical Composition Therapy for the Treatment of Cutaneous Mastocytosis - Mayo Clinic

   Topical corticosteroids;; Topical bleaching products;; Topical retinoids. Use of systemic preparations within 1 month of study entry, including: Systemic ...

2. Calcium and calcium supplements: Achieving the right balance - Mayo Clinic

   Are receiving long-term treatment with corticosteroids; Have certain bowel or digestive diseases that decrease your ability to absorb calcium, such as ...

3. Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) - Mayo Clinic

   History of intravitreal corticosteroid within 4 months of randomization. ... History of peribulbar or retrobulbar corticosteroid use for any reason within 2 ...

4. Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

   ... corticosteroids or immunosuppressive drugs); replacement therapy (e.g. ... corticosteroid replacement therapy for adrenal or pituitary insufficiency, etc.) ...

5. Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma - Mayo Clinic

   Prior high dose corticosteroid therapy for twelve days (480 mg total dose) or less is permitted for emergent complications from newly diagnosed multiple myeloma ...

6. Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery - Mayo Clinic

   No patients receiving systemic corticosteroids (either intravenous [IV] or oral steroids, excluding inhalers or low-dose hormone replacement therapy) within ...

7. Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment - Mayo Clinic

   - An emergency use of a short course of corticosteroids (equivalent of dexamethasone 160 mg) any time before registration, or - Up to one complete cycle of ...

8. A Study of SC-006 in Subjects With Advanced Cancer - Mayo Clinic

   ... corticosteroids. Definitive treatment may include surgical resection, whole brain irradiation, and/or stereotactic radiation therapy. Recovery to Grade 1 of ...

9. A Study to Evaluate the Safety, Pharmacokinetics and Biodistribution of an Imaging Agent, 18F-OP-801 (18F Hydroxyl Dendrimer) in Patients With Amyotrophic Lateral Sclerosis (ALS) and Healthy Volunteers (HV) - Mayo Clinic

   Corticosteroid treatment (e.g., prednisone, solumedrol) within 30 days of Baseline 13. Treatment with any of the following classes of nonsteroidal anti ...

10. A Study to Assess the Effectiveness and Safety of Ublituximab in combination with Umbralisib and Venetoclax (U2-V) Compared to Ublituximab and Umbralisib (U2) in Subjects with Chronic Lymphocytic Leukemia (CLL) - Mayo Clinic

    Corticosteroid use within 1 week prior to first dose of study drug are ... corticosteroids. Patients requiring systemic steroids for leukemia control ...